Skip to main content
Caplight Logo









Neumarker Inc.

Neumarker Inc.

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://neumarker.ai/

Last Round

Grant

Nov 12, 2024

Total Funding Raised

$3M

Company Overview

Neumarker Inc. operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Grant round in November 2024.

Neumarker Inc. is a biotechnology company that develops AI-powered brain biomarker technology to analyze brain function for precision neuromedicine and CNS drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Clinical Trials, Mental Health, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Neumarker Inc. Comparables

Compare Neumarker Inc. with similar companies based on industry and business-model similarity.

Neumarker Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brainify.AI
84%
Pabel B.V.
84%
Cumulus Neuroscience
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Neumarker Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 12, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Neumarker Inc. Investors

Notable investors and investment history

Neumarker Inc. investors
InvestorRounds
Foothill VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Grew 23% QoQ from 13 to 16 employees.

  • May 2, 2026

    Grew 25% QoQ, from 12 to 15 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Neumarker Inc. Filings

Explore SEC and related filing metadata, where available.

Neumarker Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Neumarker Inc.'s valuation, stock price, and market status.

Is Neumarker Inc. a public or private company?

Neumarker Inc. is a private company.

What is the current stock price of Neumarker Inc.?

Neumarker Inc. is a private company, so its shares have no public market price. Caplight tracks Neumarker Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Neumarker Inc. worth (valuation)?

Valuation information for Neumarker Inc. is not publicly available.

Can I buy Neumarker Inc. stock?

Neumarker Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Neumarker Inc.'s last funding round?

Neumarker Inc.'s most recent funding round was Grant on November 12, 2024.

Who are the main investors in Neumarker Inc.?

Key investors in Neumarker Inc. include Foothill Ventures.

Will Neumarker Inc. IPO soon?

No public IPO plans have been announced for Neumarker Inc..

How can I track Neumarker Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Neumarker Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range16
Year Founded2022
Last FundingNov 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?